CD BioGlyco, a leading innovator in glycobiology products and services, announced the launch of its new line of high-quality enzymes specifically designed for research purposes. This comprehensive expansion features a diverse range of glycosyltransferases, exoglycosidases, and endoglycosidases, etc., empowering researchers with cutting-edge tools to delve deeper into the fascinating world of glycans.
Glycans, intricate sugar chains attached to proteins and lipids, play a pivotal role in numerous biological processes, influencing cell communication, immune response, and even disease development. Unraveling the mysteries of these complex molecules requires specialized tools, and CD BioGlyco's new enzyme line fills a critical gap in the research community.
"We are thrilled to expand our offerings with this new line of glycobiology-related enzymes," stated Anna, one of the representative speakers at CD BioGlyco. "This commitment reflects our unwavering dedication to equipping researchers with the latest advancements and resources necessary to unlock the secrets of glycan biology."
CD BioGlyco's new enzyme offerings boast several key advantages:
Unmatched Activity and Specificity: Utilizing state-of-the-art technology, these enzymes exhibit exceptional activity and specificity towards their target substrates, ensuring researchers obtain accurate, reliable results.
Broad Application Scope: Encompassing glycosyltransferases, exoglycosidases, and endoglycosidases, this line provides researchers with diverse tools for various applications, including:
- Glycan profiling: Accurately determining the structure and composition of glycans attached to proteins and lipids.
- Protein modification analysis: Investigating the functional impact of glycans on protein function and signaling pathways.
- Sequence research: Deciphering the biosynthetic pathways and genetic basis of glycan diversity.
- Drug development: Identifying and developing novel therapeutics targeting glycan-mediated pathways.
Competitive Pricing: Recognizing the importance of accessibility, CD BioGlyco offers its new enzyme line at competitive prices, enabling researchers to conduct cutting-edge glycan research without compromising budget constraints.
Some of the glycobiology-related enzymes provided by CD BioGlyco include:
Recombinant Plesiomonas shigelloides O17 UDP-GlcNAc 4-epimerase, E. coli
Recombinant E. coli O157:H7 inorganic pyrophosphatase
Recombinant Helicobacter pylori α-1,3/4-fucosyltransferase, E. coli
…
Glycoanalytical Enzymes
Formate dehydrogenase from Candida boidinii
Hexokinase/Glucose-6-phosphate dehydrogenase from yeast
Glucose-6-phosphate isomerase from Bacillus subtilis
…
α-L-Arabinofuranosidase from Aspergillus niger
Cellobiohydrolase I from Trichoderma longibrachiatum
α-Fucosidase from Thermotoga maritima
…
"Our commitment goes beyond simply offering a new product line," Anna added. "We actively collaborate with leading research institutions and participate in scientific conferences and workshops, fostering a vibrant and collaborative glycan research community."
With the launch of its new enzyme line, CD BioGlyco solidifies its position as a leading provider of glycobiology solutions. Researchers across the globe can now leverage these high-quality tools to unlock the secrets of glycans and pave the way for ground-breaking discoveries in diverse fields of scientific inquiry.
To know more about the glycobiology-related enzymes products provided by CD BioGlyco, please visit https://www.bioglyco.com/products/enzyme.html.
About CD BioGlyco
CD BioGlyco is a leading provider of specialized products and services catering to the rapidly growing field of glycobiology. Driven by innovation and quality, CD BioGlyco empowers researchers worldwide to unlock the complexities of glycans and their critical roles in human health and disease. Their comprehensive portfolio includes enzymes, carbohydrate, glycans, glycoprotein analysis, and custom services, providing researchers with the resources they need to advance their scientific endeavors.